Cytokinetics Inc vs Gartner Inc — how do they compare? Cytokinetics Inc trades at $82.03 (market cap $11.16B), while Gartner Inc trades at $132.89 (market cap $9.46B). The key difference: Cytokinetics Inc is the larger of the two by market cap, and Cytokinetics Inc is trading nearer its 52-week high, Gartner Inc nearer its low. Which is the better fit depends on your goals.
| CYTK | IT | |
|---|---|---|
Market Cap | $11.16B | $9.46B |
Sector | Technology | Technology |
52-Week High | $87.26 | $363.58 |
52-Week Low | $33.23 | $125.68 |
Enterprise Value | $11.63B | $11.05B |
Trailing returns across standard periods
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →Based in Stamford, Conn., Gartner provides independent research and analysis on information technology and other related technology industries. Its research is delivered to clients' desktops in the form of reports, briefings, and updates. Typical clients are chief information officers and other business executives who help plan companies' IT budgets. Gartner also provides consulting services and hosted nearly 80 IT conferences across the globe in 2007.
Read more on IT →